This pharma giant's recent run is grabbing headlines, but its long-term behavior tells a more interesting story about ...

The pharma titan is expanding into new markets.

SpaceX recently completed a record IPO.

Eli Lilly has made some massive breakthroughs in pharmaceutical technology, but will it translate to money for investors? Read our forecast and find out.

Eli Lilly holds a dominant market share in the weight loss treatment category.

The weight loss tailwind isn't about to come to a halt.

More than just a simple rise, the pharmaceutical company's stock has been re-evaluated due to a growth narrative that continues to expand.

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43. We rate LLY a buy with a 90% confidence score.

At first glance, Eli Lilly's (NYSE: LLY) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assume anything this expensive must be priced ...

It's been a tough start for Eli Lilly (NYSE: LLY) stock this year. Entering this week, the pharmaceutical giant's value has fallen by 8%. While its five-year gains are still impressive at around 380%, ...

Shares of Eli Lilly and Company LLY have declined 5.2% in the past month despite the company reporting robust fourth-quarter 2025 results on Feb. 4. Industry pricing concerns, rising competitive ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, ...